Listening to the elephant in the room: response-shift effects in clinical trials research

被引:5
|
作者
Schwartz, Carolyn E. [1 ,2 ,3 ]
Huang, I. -Chan [4 ]
Rohde, Gudrun [5 ,6 ]
Skolasky, Richard L. [7 ]
机构
[1] DeltaQuest Fdn Inc, 31 Mitchell Rd, Concord, MA 01742 USA
[2] Tufts Univ, Dept Med, Med Sch, Boston, MA 02111 USA
[3] Tufts Univ, Dept Orthopaed Surg, Med Sch, Boston, MA 02111 USA
[4] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA
[5] Univ Agder, Fac Hlth & Sport Sci, Sorlandet Hosp, Dept Clin Res, Kristiansand, Norway
[6] UCL, Div Psychiat, Marie Curie Palliat Care Res Dept, London, England
[7] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD USA
关键词
Response shift; Clinical trials; Scoping review; Outcomes; QUALITY-OF-LIFE; HEALTH; CANCER; INTERVENTION; CARE; PERCEPTION; MODELS; STROKE; POWER; BIAS;
D O I
10.1186/s41687-022-00510-6
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background While a substantial body of work postulates that adaptation (response-shift effects) may serve to hide intervention benefits, much of the research was conducted in observational studies, not randomized-controlled trials. This scoping review identified all clinical trials that addressed response shift phenomena, and characterized how response-shift effects impacted trial findings. Methods A scoping review was done of the medical literature from 1968 to 2021 using as keywords "response shift" and "clinical trial." Articles were included if they were a clinical trial that explicitly examined response-shift effects; and excluded if they were not a clinical trial, a full report, or if response shift was mentioned only in the discussion. Clinical-trials papers were then reviewed and retained in the scoping review if they focused on randomized participants, showed clear examples of response shift, and used reliable and valid response-shift detection methods. A synthesis of review results further characterized the articles' design characteristics, samples, interventions, statistical power, and impact of response-shift adjustment on treatment effect. Results The search yielded 2148 unique references, 25 of which were randomized-controlled clinical trials that addressed response-shift effects; 17 of which were retained after applying exclusion criteria; 10 of which were adequately powered; and 7 of which revealed clinically-important response-shift effects that made the intervention look significantly better. Conclusions These findings supported the presumption that response shift phenomena obfuscate treatment benefits, and revealed a greater intervention effect after integrating response-shift related changes. The formal consideration of response-shift effects in clinical trials research will thus not only improve estimation of treatment effects, but will also integrate the inherent healing process of treatments.
引用
收藏
页数:14
相关论文
共 20 条
  • [1] Listening to the elephant in the room: response-shift effects in clinical trials research
    Carolyn E. Schwartz
    I.-Chan Huang
    Gudrun Rohde
    Richard L. Skolasky
    Journal of Patient-Reported Outcomes, 6
  • [2] If it's information, it's not "bias": a scoping review and proposed nomenclature for future response-shift research
    Schwartz, Carolyn E.
    Rohde, Gudrun
    Biletch, Elijah
    Stuart, Richard B. B.
    Huang, I-Chan
    Lipscomb, Joseph
    Stark, Roland B.
    Skolasky, Richard L.
    QUALITY OF LIFE RESEARCH, 2022, 31 (08) : 2247 - 2257
  • [3] Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating
    Schwartz, Carolyn E.
    Stark, Roland B.
    Stucky, Brian D.
    Li, Yuelin
    Rapkin, Bruce D.
    QUALITY OF LIFE RESEARCH, 2021, 30 (05) : 1283 - 1292
  • [4] Response-shift effects in childhood cancer survivors: A prospective study
    Huang, I-Chan
    Sim, Jin-ah
    Srivastava, DeoKumar
    Krull, Kevin R.
    Ness, Kirsten K.
    Robison, Leslie L.
    Baker, Justin N.
    Hudson, Melissa M.
    Schwartz, Carolyn E.
    PSYCHO-ONCOLOGY, 2023, 32 (07) : 1085 - 1095
  • [5] Response-shift effects in neuromyelitis optica spectrum disorder: a secondary analysis of clinical trial data
    Carolyn E. Schwartz
    Roland B. Stark
    Brian D. Stucky
    Quality of Life Research, 2021, 30 : 1267 - 1282
  • [6] Response-shift effects in neuromyelitis optica spectrum disorder: a secondary analysis of clinical trial data
    Schwartz, Carolyn E.
    Stark, Roland B.
    Stucky, Brian D.
    QUALITY OF LIFE RESEARCH, 2021, 30 (05) : 1267 - 1282
  • [7] Impact of response shift on longitudinal quality-of-life assessment in cancer clinical trials
    Hamidou, Zeinab
    Dabakuyo, Tienhan Sandrine
    Bonnetain, Franck
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2011, 11 (05) : 549 - 559
  • [8] If it’s information, it’s not “bias”: a scoping review and proposed nomenclature for future response-shift research
    Carolyn E. Schwartz
    Gudrun Rohde
    Elijah Biletch
    Richard B. B. Stuart
    I.-Chan Huang
    Joseph Lipscomb
    Roland B. Stark
    Richard L. Skolasky
    Quality of Life Research, 2022, 31 : 2247 - 2257
  • [9] Response-shift effects in neuromyelitis optica spectrum disorder: estimating response-shift-adjusted scores using equating
    Carolyn E. Schwartz
    Roland B. Stark
    Brian D. Stucky
    Yuelin Li
    Bruce D. Rapkin
    Quality of Life Research, 2021, 30 : 1283 - 1292
  • [10] Clinical Trials [and Tribulations]: The Immediate Effects of COVID-19 on IBD Clinical Research Activity in the UK
    Noor, Nurulamin M.
    Hart, Ailsa L.
    Irving, Peter M.
    Ghosh, Subrata
    Parkes, Miles
    Raine, Tim
    JOURNAL OF CROHNS & COLITIS, 2020, 14 (12) : 1769 - 1776